2019 American Transplant Congress Archives - Page 13 of 214

4:30pm-4:42pm: Preserved Heart Rate Variability and Endothelial Function One Year after Pancreas Transplantation

E. Nordheim, T. Halden, K. Birkeland, A. Åsberg, T. Jenssen

Concurrent Session: Pancreas and Islet: All Topics II • Room 209

4:30pm-4:42pm: The Protective Effects of siRNA Conjugated Nanoparticles in Pancreatic Islet Cells after Transplant

T. Pomposelli, P. Wang, Y. Ariyoshi, K. Takeuchi, C. Schuetz, A. Moore, K. Yamada

Concurrent Session: Islet and Cell Transplantation • Room 309

4:30pm-4:42pm: Transplanting Thoracic Organs From Hcv Donors To Uninfected Patients: Evaluation Of Lung Allografts

Y. Lo¹, R. F. Padera¹, H. R. Mallidi², H. J. Goldberg³, S. K. Singh², A. Coppolino, III⁴, L. R. Baden⁵, A. E. Woolley⁵

Concurrent Session: Infections, Antibodies and Biomarkers in Lung Transplantation • Room 206

4:42pm-4:54pm: Association between Medicaid Expansion under the Affordable Care Act and Preemptive Kidney Transplantation of Low-Income Medicaid Beneficiaries

M. N. Harhay¹, R. McKenna²

Concurrent Session: Non-Organ Specific: Public Policy & Allocation • Room 311

4:42pm-4:54pm: Biomarker Candidate Discovery for Kidney Allograft Monitoring via Urinary Exosome Proteome Analysis

J. Kim¹, Y. Wee¹, M. Choi¹, H. Jung¹, J. Choi¹, H. Kwon¹, J. Jung¹, Y. Ko¹, D. Kim¹, K. Kim², Y. Cho³, H. Go³, Y. Kim¹, D. Han¹, S. Shin¹

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes III • Room 306

4:42pm-4:54pm: Clazakizumab (CLZ, Anti-IL-6 Antibody) and Tocilizumab (TCZ, Anti-IL-6 Receptor [r] Antibody) Treatments Differentially Affect IL-6/IL-6R Signaling by Modulating Soluble IL-6R (sIL-6R) and gp130 (sgp130) in Kidney Transplant Patients (KTx Pts) Treated for Chronic Antibody-Mediated Rejection (cABMR)

B. Shin, S. Ge, A. Petrosyan, N. F. Ammerman, A. A. Vo, S. C. Jordan, M. Toyoda

Concurrent Session: Kidney Chronic Antibody Mediated Rejection • Ballroom B

4:42pm-4:54pm: Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Donor-Specific Anti-HLA Antibodies and Calcineurin Inhibitor Nephrotoxicity Decreases the Pathogenicity of Donor-Specific Anti-HLA Antibodies

K. Louis¹, D. Viglietti¹, D. Pievani¹, O. Aubert¹, D. Glotz¹, C. Legendre¹, A. Zeevi², A. Loupy¹, C. Lefaucheur¹

Concurrent Session: Kidney Immunosuppression: Novel Regimens and Drug Minimization II • Veterans Auditorium

4:42pm-4:54pm: Donor Graft CMV Serostatus Influences the Development of Arterial and Venous Vascular Events in Seronegative Recipients after Organ Transplantation

S. Belga, C. MacDonald, D. Chiang, D. Kabbani, S. Shojai, J. G. Abraldes, C. Cervera

Concurrent Session: Breakthroughs in Cytomegalovirus • Ballroom A

4:42pm-4:54pm: Epstein Barr Virus (EBV)-Specific T Cells as a Diagnostic Marker for the Individual EBV-Specific Immune Response after Pediatric Kidney Transplantation

T. Ahlenstiel-Grunow, L. Pape

Concurrent Session: Kidney: Pediatrics II • Room 304

4:42pm-4:54pm: High Fibre Diet Prevents Transplant-Associated Dysbiosis and Prevents Kidney Allograft Rejection

J. J. Singer¹, H. Wu¹, T. Kwan¹, Y. Loh¹, C. Wang¹, J. Tan², L. Macia², S. Alexander³, S. Chadban¹

Concurrent Session: Tolerance / Immune Deviation • Room 310